Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) and the effect of antiresorptive treatment on glycemic markers
This research is investigating how a medicine called Alendronate, commonly used to treat weak bones (osteoporosis) and bone thinning (osteopenia), affects people with diabetes. The study aims to understand if taking this bone medicine changes important measures of blood sugar control, like HbA1c, as well as bone density. Researchers will compare people taking Alendronate to those taking a placebo (a dummy pill) to see the differences. It's a Phase IV study, meaning the medicine is already approved for use, and this research is looking at its effects in a specific group of patients, focusing on its impact on both bone health and blood sugar levels. This could help doctors better understand how to manage bone health in people living with diabetes.
At a glance
What is this study about?
This study is looking at an important health topic for people with diabetes. We know that diabetes can sometimes affect bone health, making bones weaker or more likely to break. Doctors often prescribe medicines to strengthen bones, especially for conditions like osteopenia (bone thinning) or osteoporosis (very weak bones).
This particular study wants to see what happens when people with either type 1 or type 2 diabetes, who also have weak bones, take a common bone-strengthening medicine called Alendronate. The main thing they're interested in is whether this medicine changes a person's blood sugar control, as measured by something called HbA1c, and also how it affects their bone density, which is a measure of how strong their bones are. They will compare these effects to a group of people who receive a placebo, which looks like the medicine but has no active ingredients.
By doing this research, scientists hope to learn more about how bone medicines might interact with diabetes, specifically with blood sugar levels and bone strength. This information could be very helpful for doctors in the future when deciding on the best treatments for people who have both diabetes and bone problems, ensuring their care is as safe and effective as possible.
Key takeaways
- This study explores how a bone-strengthening medicine affects people with diabetes.
- It focuses on changes in blood sugar control (HbA1c) and bone density.
- This research involves taking a medicine or a placebo, and having regular health checks.
- The findings could help doctors better care for people with both diabetes and bone problems.
- Participants must have type 1 or type 2 diabetes and either osteopenia or osteoporosis.
Who may be eligible?
This study is looking for adults aged 18 and older. Both men and women can take part. To be suitable, you would need to have been diagnosed with either type 1 or type 2 diabetes. Additionally, you would need to have either osteopenia, which means your bones are thinner than average, or osteoporosis, where your bones are significantly weakened.
There might be other specific health requirements or conditions that would mean you couldn't join, which the study team would discuss with you. For example, if you are currently taking other medications that could interfere with the study medicine, or if you have certain other health issues, you might not be able to participate.
The best way to find out if you qualify is to speak with the study team. They will ask you detailed questions about your health and medical history to confirm if this study is a good fit for you.
- Are you 18 years old or older?
- Have you been diagnosed with type 1 or type 2 diabetes?
- Do you also have osteopenia (bone thinning) or osteoporosis (weak bones)?
- Are you able to attend regular study appointments and follow instructions?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you join this study, you will be given either the active bone medicine (Alendronate) or a placebo (a dummy pill). You won't know which one you are taking. You'll have regular visits to the clinic where the study team will take blood samples to check your blood sugar (like HbA1c and insulin levels) and various bone markers. They will also measure your bone density using a special scan called a BMD scan, and some participants might have more detailed bone scans (HRpQCT).
Other assessments might include checking your urine, taking samples of fat, muscle, or bone tissue if needed, and completing questionnaires about your lifestyle, diet, and physical activity. The study team will track these measurements over a period of time to see how your body responds to the treatment. They will explain the full schedule of visits and tests, and you will have support throughout the study.
Potential risks and benefits
Locations (1)
- —Denmark
Common questions
What is Alendronate?
Alendronate is a medication commonly prescribed to help strengthen bones and reduce the risk of fractures in people with thin or weak bones, like osteopenia or osteoporosis.
What does HbA1c mean?
HbA1c is a blood test that shows your average blood sugar levels over the past 2-3 months. It's a key measurement for people with diabetes.
What is bone density?
Bone density is a measurement of how strong and thick your bones are. Higher density usually means stronger bones that are less likely to break.
Why is a placebo used in the study?
A placebo helps researchers compare the effects of the active medicine against a dummy pill. This helps them know if any changes observed are truly due to the medicine or other factors.
Will I know if I'm getting the active medicine or the placebo?
No, this type of study is usually 'blinded,' meaning neither you nor the study team will know if you are receiving the active medicine or the placebo until the study is over. This helps ensure the results are unbiased.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.